Atlas FDA

Alinity m CMV Assay

FDA premarket approval P210022/S012 · decided 2024-09-13

Approval details

PMA number
P210022
Supplement
S012
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Alinity m CMV Assay
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Applicant
Abbott Molecular, Inc.
Date received
2024-06-18
Decision date
2024-09-13
Days to decision
87 days
Decision code
APPR
Product code
PAB
Advisory committee
Microbiology
Expedited review
No
Location
Des Plaines, IL
Statement
Approval to add AMP Detect insert bar on the Amplification Detection Unit (ADU) ejection bar of the Alinity m System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15